ReplyThe Prescription Cost Analysis data release gives items and quantities of each medicine dispensed in the community in England. The following table shows the total number of items dispensed for analgesics in England, regardless of where prescribed, as well as the unique number of patients that were dispensed medicines listed in British National Formulary (BNF) Section 4.7 Analgesics, from December 2023 to November 2024:Month and yearTotal number of itemsUnique identified patientsDecember 20235,000,0003,100,000January 20245,200,0003,200,000February 20244,800,0003,100,000March 20244,900,0003,100,000April 20245,100,0003,200,000May 20245,200,0003,200,000June 20244,800,0003,100,000July 20245,200,0003,200,000August 20245,000,0003,100,000September 20244,900,0003,100,000October 20245,200,0003,200,000November 20245,000,0003,200,000Total60,400,0007,500,000For further information, BNF 4.7 includes:- non-opioid analgesics and compound preparations;- opioid analgesics;- neuropathic pain medicines; and- antimigraine medicines.No data has been captured relating to the clinical indication a prescription is intended for. Some of these products can be used for a variety of clinical indications and therefore the figures provided may include items that were prescribed for a different condition, rather than for pain relief.It is important to note that this data does not capture medicines classified elsewhere within the BNF, which are primarily used for other reasons, but may also be used for analgesic purposes. This includes, for example, non-steroidal anti-inflammatory drugs, which feature in 10.1 ‘Drugs used in rheumatic diseases and gout’, and antidepressants, used off-label in chronic primary pain, which feature in 4.3 ‘Antidepressant drugs’.